Molecular Dx

Researchers at Harvard Medical School have sequenced the genomes of a family in which multiple members had pancreatic cancer and found a mutation in a gene linked to the RAS signaling pathway that controls cell growth and death. Researchers argue that the into how RABL3 impacts the signaling pathway could lead to novel targeted therapy.

GNA Biosolutions GmbH's new funding will spur the German company’s molecular diagnostics assay development.

GeneCentric Therapeutics said today it has entered the second phase of a diagnostic development collaboration with Jose Zevallos M.D., M.P.H., Chief of the Division...

Myriad Genetics said today it will pursue FDA authorization of its BRACAnalysis CDx test as a companion diagnostic for the AstraZeneca/Merck & Co. co-marketed...

The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...

The companies will co-commercialize their respective single-cell technologies for CTCs and PD-L1 expression following positive study results

The new findings from the Ontario Institute for Cancer Research provide important insights into how pancreatic cancer develops and spreads.

It would be hard to find an area of health where the microbiome has not been implicated as a major player. The microbiome is...

The American College of Medical Genetics and Genomics (ACMG) said today it will establish a program designed to develop new evidence-based guidelines in medical...

Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.